small lymphocytic lymphoma

URI: https://gptkb.org/entity/small_lymphocytic_lymphoma
GPTKB entity
Statements (51)
Predicate Object
gptkbp:instanceOf gptkb:disease
leukemia
gptkbp:affects lymphocytes
gptkbp:alsoKnownAs SLL
gptkbp:class gptkb:WHO_classification_of_lymphoid_neoplasms
gptkbp:hasCellMarker gptkb:CD20
gptkb:CD19
gptkb:CD23
gptkb:CD43
CD5
gptkbp:hasDiagnosticMethod immunophenotyping
lymph node biopsy
flow cytometry
gptkbp:hasGeneticAlteration gptkb:del(13q)
gptkb:trisomy_12
del(11q)
del(17p)
gptkbp:hasPrognosticMarker gptkb:ZAP-70
gptkb:beta-2_microglobulin
IGHV mutation status
https://www.w3.org/2000/01/rdf-schema#label small lymphocytic lymphoma
gptkbp:ICD-10_code gptkb:C83.0
gptkbp:isIndolent true
gptkbp:isSlowGrowing true
gptkbp:medianAge 60 years
gptkbp:originatedIn gptkb:B_cells
gptkbp:prevalence rare
gptkbp:prognosis indolent
gptkbp:relatedTo leukemia
chronic lymphocytic leukemia
gptkbp:riskFactor age
male sex
family history of lymphoma
gptkbp:stageName gptkb:Ann_Arbor_staging
gptkb:Rai_staging_(for_CLL)
gptkbp:subspecies leukemia
gptkbp:symptom fever
fatigue
weight loss
lymphadenopathy
night sweats
gptkbp:synonym SLL
gptkbp:transformsInto diffuse large B-cell lymphoma
gptkbp:treatment chemotherapy
oncologist
immunotherapy
hematologist
targeted therapy
gptkbp:bfsParent gptkb:duvelisib
gptkb:idelalisib
gptkbp:bfsLayer 5